Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market

PALM BEACH GARDENS, FL--(Marketwire - March 27, 2008) - Pegasus Pharmaceuticals (PINKSHEETS: PGUZ) today announced that it has filed for patents for its innovative biological product, MOLD GONEā„¢. Pegasus is engaged in the research, development and marketing of anti-microbial compositions and systems for killing, inhibiting and growth prevention of fungal matter such as live cells, spores and mycotoxins associated with molds.

Back to news